Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Emidas
- Development stage
- Unknown
- Lead developer
- Med Manor Organics
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Emidas is a fixed-dose combination tablet developed by Med Manor Organics, primarily used for the treatment of vertigo, Ménière's disease, and tinnitus. It contains four active ingredients: betahistine (a histamine analogue), ginkgo biloba (a botanical extract), piracetam (a nootropic), and vinpocetine (a synthetic derivative of the vinca alkaloid vincamine). Together, these components work synergistically to improve blood flow to the inner ear and brain, reduce fluid pressure in the inner ear, protect the nervous system against hypoxia, and alleviate symptoms such as dizziness, spinning sensations, and loss of balance.
- Brand names
- EmidasEmidas LS
- Other names
- betahistine + ginkgo biloba + piracetam + vinpocetine
02
Targets
AMPAR (AMPA receptor)HRH1 (Histamine H1 Receptor)HRH3 (Histamine Receptor H3)PDE1 (Phosphodiesterase 1)PTAFR (Platelet-activating factor receptor)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on Emidas.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Emidas.